GCP
NVCR icon

GSA Capital Partners’s NovoCure NVCR Stock Holding History

GSA Capital Partners’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-35,582
Closed -$388K – 2040
2026
Q1 		$388K Buy
35,582
+25,121
+240% +$314K 0.02% 1079
2025
Q4 		$135K Buy
+10,461
New +$134K 0.01% 1493
2025
Q2 		– Sell
-55,527
Closed -$989K – 2021
2025
Q1 		$989K Buy
+55,527
New +$1.26M 0.09% 353
2023
Q2 		– Sell
-3,498
Closed -$210K – 1815
2023
Q1 		$210K Buy
+3,498
New +$280K 0.02% 1235
2022
Q3 		– Sell
-8,462
Closed -$588K – 1768
2022
Q2 		$588K Buy
+8,462
New +$637K 0.09% 395
2020
Q4 		– Sell
-2,181
Closed -$243K – 1485
2020
Q3 		$243K Buy
+2,181
New +$174K 0.04% 881
2020
Q1 		– Sell
-2,400
Closed -$202K – 1403
2019
Q4 		$202K Sell
2,400
-1,920
-44% -$155K 0.02% 1254
2019
Q3 		$323K Sell
4,320
-12,945
-75% -$1.04M 0.04% 831
2019
Q2 		$1.09M Sell
17,265
-4,871
-22% -$247K 0.12% 200
2019
Q1 		$1.07M Buy
22,136
+10,236
+86% +$493K 0.11% 268
2018
Q4 		$398K Sell
11,900
-17,300
-59% -$633K 0.05% 674
2018
Q3 		$1.53M Sell
29,200
-20,300
-41% -$808K 0.08% 399
2018
Q2 		$1.55M Buy
49,500
+29,100
+143% +$809K 0.08% 428
2018
Q1 		$445K Sell
20,400
-7,700
-27% -$166K 0.02% 1127
2017
Q4 		$568K Buy
28,100
+4,000
+17% +$77K 0.03% 880
2017
Q3 		$478K Buy
+24,100
New +$474K 0.03% 1000
2016
Q1 		– Sell
-14,300
Closed -$320K – 1846
2015
Q4 		$320K Buy
+14,300
New +$342K 0.02% 1428

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

GSA Capital Partners's NVCR Position: Q2 2026 in Review

GSA Capital Partners sold out of NovoCure (NVCR) in Q2 2026, closing a stake of 35,582 shares — an estimated $388K sold.

GSA Capital Partners first reported a position in NVCR in Q4 2015 and held it in 17 quarters. The position peaked at $1.55M in Q2 2018. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • GSA Capital Partners reported no remaining NovoCure position as of Q2 2026 after selling out during the quarter.
  • GSA Capital Partners sold 35,582 NovoCure shares in Q2 2026, an estimated $388K.
  • GSA Capital Partners first reported a position in NovoCure in Q4 2015 and held it in 17 quarters.
  • GSA Capital Partners's NovoCure position peaked at $1.55M in Q2 2018.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.